Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.

Huang CM, Huang CS, Hsu TN, Huang MS, Fong IH, Lee WH, Liu SC.

Cells. 2019 Dec 18;9(1). pii: E7. doi: 10.3390/cells9010007.

2.

Early Life Exposure to Air Pollution and Incidence of Childhood Asthma, Allergic Rhinitis and Eczema.

To T, Zhu J, Stieb D, Gray N, Fong I, Pinault L, Jerrett M, Robichaud A, Ménard R, van Donkelaar A, Martin RV, Hystad P, Brook JR, Dell S.

Eur Respir J. 2019 Dec 5. pii: 1900913. doi: 10.1183/13993003.00913-2019. [Epub ahead of print]

PMID:
31806712
3.

Sex differences in health services and medication use among older adults with asthma.

To T, Gray N, Ryckman K, Zhu J, Fong I, Gershon A.

ERJ Open Res. 2019 Dec 2;5(4). pii: 00242-2019. doi: 10.1183/23120541.00242-2019. eCollection 2019 Oct.

4.

Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma.

Liu HW, Lee PM, Bamodu OA, Su YK, Fong IH, Yeh CT, Chien MH, Kan IH, Lin CM.

Cancers (Basel). 2019 Nov 27;11(12). pii: E1888. doi: 10.3390/cancers11121888.

5.

Low prevalence of the BCR-ABL1 fusion gene in a normal population in southern Sarawak.

Kuan JW, Su AT, Tay SP, Fong IL, Kubota S, Su'ut L, Osato M, Sashida G.

Int J Hematol. 2019 Nov 9. doi: 10.1007/s12185-019-02768-x. [Epub ahead of print]

PMID:
31707540
6.

Reliability of the Maximal Step Length Test and Its Correlation with Motor Function in Chronic Stroke Survivors.

Ng SSM, Tse MMY, Kwong PWH, Fong ICK, Chan SH, Cheung TCH, Ko HL, Yan DMH, Lai CYY.

Biomed Res Int. 2018 Dec 20;2018:6985963. doi: 10.1155/2018/6985963. eCollection 2018.

7.

Mandibular osteomyelitis due to Raoultella species.

Lam PW, Tadros M, Fong IW.

JMM Case Rep. 2018 Jan 22;5(3):e005140. doi: 10.1099/jmmcr.0.005140. eCollection 2018 Mar.

8.

Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients: A Retrospective Review.

Naccarato MJ, Yoong DM, Fong IW, Gough KA, Ostrowski MA, Tan DHS.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325957417752260. doi: 10.1177/2325957417752260.

9.

Effect of foot progression angle adjustment on the knee adduction moment and knee joint contact force in runners with and without knee osteoarthritis.

Fong ICD, Li WSC, Tai WKJ, Tsang TWR, Zhang JH, Chen TLW, Baur H, Eichelberger P, Cheung RTH.

Gait Posture. 2018 Mar;61:34-39. doi: 10.1016/j.gaitpost.2017.12.029. Epub 2017 Dec 30.

PMID:
29304509
10.

Dolutegravir and metformin: a case of hyperlactatemia.

Naccarato M, Yoong D, Fong IW.

AIDS. 2017 Sep 24;31(15):2176-2177. doi: 10.1097/QAD.0000000000001617. No abstract available.

PMID:
28906282
11.

Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.

Kuok CF, Hoi SO, Hoi CF, Chan CH, Fong IH, Ngok CK, Meng LR, Fong P.

Exp Biol Med (Maywood). 2017 Apr;242(7):731-743. doi: 10.1177/1535370216689828. Epub 2017 Jan 1.

12.

Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.

Huang WJ, Jeng YM, Lai HS, Fong IU, Sheu FY, Lai PL, Yuan RH.

PLoS One. 2015 Mar 4;10(3):e0119181. doi: 10.1371/journal.pone.0119181. eCollection 2015.

13.

The CER (Comparative Effectiveness Research) collaborative toolkit.

Cheung E, Du R, Fong I, Lee T.

J Manag Care Spec Pharm. 2014 Aug;20(8):770. No abstract available.

14.

Amiodarone and concurrent antiretroviral therapy: a case report and review of the literature.

Naccarato M, Yoong D, la Porte C, Fong I.

Antivir Ther. 2014;19(4):329-39. doi: 10.3851/IMP2715. Epub 2013 Dec 3. Review.

PMID:
24296729
15.

New perspectives of infections in cardiovascular disease.

Fong IW.

Curr Cardiol Rev. 2009 May;5(2):87-104. doi: 10.2174/157340309788166679.

16.

APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo.

Sale S, Fong IL, de Giovanni C, Landuzzi L, Brown K, Steward WP, Gescher AJ.

Eur J Cancer. 2009 Nov;45(16):2731-5. doi: 10.1016/j.ejca.2009.07.004. Epub 2009 Aug 18.

PMID:
19695862
17.

Synthesis of the flavonoid 3',4',5'-trimethoxyflavonol and its determination in plasma and tissues of mice by HPLC with fluorescence detection.

Britton RG, Fong I, Saad S, Brown K, Steward WP, Gescher A, Sale S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 1;877(10):939-42. doi: 10.1016/j.jchromb.2009.02.043. Epub 2009 Feb 24.

PMID:
19282252
18.

A proteome reference map of Trichomonas vaginalis.

Huang KY, Chien KY, Lin YC, Hsu WM, Fong IK, Huang PJ, Yueh YM, Gan RR, Tang P.

Parasitol Res. 2009 Mar;104(4):927-33. doi: 10.1007/s00436-008-1274-z. Epub 2008 Dec 5.

PMID:
19066965
19.

Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections.

Sadek M, Yue FY, Lee EY, Gyenes G, Jones RB, Hoffstein V, Munoz DG, Fong I, Ostrowski M.

Clin Vaccine Immunol. 2008 Oct;15(10):1580-9. doi: 10.1128/CVI.00173-08. Epub 2008 Aug 13. Review.

21.

An outbreak of foodborne botulism in Ontario.

Loutfy MR, Austin JW, Blanchfield B, Fong IW.

Can J Infect Dis. 2003 Jul;14(4):206-9.

22.

Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery.

Konvalinka A, Errett L, Fong IW.

J Hosp Infect. 2006 Oct;64(2):162-8. Epub 2006 Aug 23.

PMID:
16930768
23.

RAG1/2 re-expression causes receptor revision in a model B cell line.

Da Sylva TR, Fong IC, Cunningham LA, Wu GE.

Mol Immunol. 2007 Feb;44(5):889-99. Epub 2006 May 15.

PMID:
16701898
24.

Effect of antibiotics as cholesterol-lowering agents.

Jenkins DJ, Kendall CW, Hamidi M, Vidgen E, Faulkner D, Parker T, Irani N, Wolever TM, Fong I, Kopplin P, Connelly PW, Onderdonk A, Rao AV.

Metabolism. 2005 Jan;54(1):103-12.

PMID:
15562388
25.

Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents.

Morrison CF, Elzein E, Jiang B, Ibrahim PN, Marquart T, Palle V, Shenk KD, Varkhedkar V, Maa T, Wu L, Wu Y, Zeng D, Fong I, Lustig D, Leung K, Zablocki JA.

Bioorg Med Chem Lett. 2004 Jul 16;14(14):3793-7.

PMID:
15203164
26.

Fulminant Clostridium difficile colitis without diarrhea: lack of emphasis in diagnostic guidelines.

Zahariadis G, Connon JJ, Fong IW.

Am J Gastroenterol. 2002 Nov;97(11):2929-30. No abstract available.

PMID:
12425579
27.

Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.

Shafran SD, Mashinter LD, Phillips P, Lalonde RG, Gill MJ, Walmsley SL, Toma E, Conway B, Fong IW, Rachlis AR, Williams KE, Garber GE, Schlech WF, Smaill F, Pradier C.

Ann Intern Med. 2002 Nov 5;137(9):734-7.

PMID:
12416943
28.

Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques.

Fong IW, Chiu B, Viira E, Tucker W, Wood H, Peeling RW.

J Infect Dis. 2002 Nov 15;186(10):1469-73. Epub 2002 Oct 29.

PMID:
12404163
29.

Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.

Fong IW, Chiu B, Viira E, Jang D, Mahony JB.

Antimicrob Agents Chemother. 2002 Aug;46(8):2321-6.

30.

Infections and their role in atherosclerotic vascular disease.

Fong IW.

J Am Dent Assoc. 2002 Jun;133 Suppl:7S-13S. Review.

PMID:
12085725
32.

Chlamydia pneumoniae and Cardiovascular Disease.

Kolia M, Fong IW.

Curr Infect Dis Rep. 2002 Feb;4(1):35-43.

PMID:
11853655
33.

Transfusion-transmitted babesiosis in Ontario: first reported case in Canada.

Kain KC, Jassoum SB, Fong IW, Hannach B.

CMAJ. 2001 Jun 12;164(12):1721-3.

34.

Functional analysis of the human RAG 2 promoter.

Fong IC, Zarrin AA, Wu GE, Berinstein NL.

Mol Immunol. 2000 May;37(7):391-402.

PMID:
11074256
35.
36.

Collaborative multidisciplinary workshop report: what questions regarding the role of Chlamydia pneumoniae in atherosclerosis and cardiovascular disease need to be addressed utilizing animal models?

Fong IW, Quinn T, Blessing E, Kuo C, Malinverni R, Lauer M, Mawhorter S, Bachmaier K, Rosenfeld M, Taylor C, Zhong G.

J Infect Dis. 2000 Jun;181 Suppl 3:S519-20. No abstract available.

PMID:
10839751
37.

Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.

Fong IW.

J Infect Dis. 2000 Jun;181 Suppl 3:S514-8. Review.

PMID:
10839750
38.

The role of chlamydia pneumoniae in atherosclerosis - recent evidence from animal models: response

Fong IW, Chiu B, Mahony JB.

Trends Microbiol. 2000 Jun;8(6):257. No abstract available.

PMID:
10838579
39.
40.

Transfusion-transmitted babesiosis in Ontario: first reported case in Canada.

Bu Jassoum S, Fong IW, Hannach B, Kain KC.

Can Commun Dis Rep. 2000 Jan 15;26(2):9-13. English, French. No abstract available.

41.

Ethnic differences in N-glucuronidation of nicotine and cotinine.

Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P 3rd.

J Pharmacol Exp Ther. 1999 Dec;291(3):1196-203.

PMID:
10565842
42.

Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?

Fong IW, Chiu B, Viira E, Jang D, Fong MW, Peeling R, Mahony JB.

Clin Diagn Lab Immunol. 1999 Nov;6(6):891-4.

43.

Value of animal models for Chlamydia pneumoniae-related atherosclerosis.

Fong IW.

Am Heart J. 1999 Nov;138(5 Pt 2):S512-3.

PMID:
10539861
44.

De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.

Fong IW, Chiu B, Viira E, Jang D, Mahony JB.

Infect Immun. 1999 Nov;67(11):6048-55.

45.

Comparison of CMV, RSV, SV40 viral and Vlambda1 cellular promoters in B and T lymphoid and non-lymphoid cell lines.

Zarrin AA, Malkin L, Fong I, Luk KD, Ghose A, Berinstein NL.

Biochim Biophys Acta. 1999 Jul 7;1446(1-2):135-9.

PMID:
10395926
46.

In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus-infected subjects.

da Silva B, Singer W, Fong IW, Ottaway CA.

J Infect Dis. 1999 Jul;180(1):106-15.

PMID:
10353868
47.

Cervicovertebral osteitis: a complication of uvulopalatopharyngoplasty with tonsillectomy.

Haight JS, Moulton R, Fong I, Hoffstein V, Werger J, Fenton RS.

J Otolaryngol. 1999 Feb;28(1):49-50. No abstract available.

PMID:
10077784
48.

Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.

Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG.

Clin Infect Dis. 1998 Dec;27(6):1401-5.

PMID:
9868650
49.

Integrative aspects of a human model of endotoxemia.

Ottaway CA, Fong IW, da Silva B, Singer W, Karrass L.

Can J Physiol Pharmacol. 1998 May;76(5):473-8.

PMID:
9839071
50.

Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients.

Walmsley S, O'Rourke K, Mortimer C, Rachlis A, Fong I, Mazzulli T.

Clin Infect Dis. 1998 Sep;27(3):573-81.

PMID:
9770159

Supplemental Content

Support Center